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特 集：新しい時代の医療を拓く－診断と治療法の最前線－
ここまでわかるアルツハイマー病の画像診断
























































































































図１．A 健常者，B アルツハイマー病の症例の頭部 MRI
A では海馬や海馬傍回の萎縮がみられない（矢印）。一方，B では脳萎縮があり，海馬や海馬傍回の萎縮が強く認められる（矢頭）。








図３．A 集積陽性，B 集積陰性の症例のアミロイド PET
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SUMMARY
In this article, we describe the various diagnostic imaging examinations currently used for
evaluating dementia, with a focus on Alzheimer’s disease. There are many diseases that cause
dementia, and Alzheimer’s disease is a typical disease, accounting for about６７．６％ of dementia cases
in patients ６５years old. Naturally, it is not possible to diagnose dementia based on an imaging
examination alone, but the importance of such examinations as powerful auxiliary tools has been
widely recognized. Computed tomography and magnetic resonance imaging can confirm the pre-
sence of intracranial diseases, such as brain tumors, chronic subdural hematoma, normal-pressure
hydrocephalus and other treatable diseases, as well as cerebral atrophy. Brain perfusion scintigra-
phy using compounds labeled with a radioisotope, such as１２３I, can visualize the blood flow distribu-
tion in the brain. After the non-linear transformation to Talairach’s standard brain coordinates,
comparing it with a normal database, it is possible to objectively and accurately depict the site of
blood flow reduction. Cardiac scintigraphy using１２３I-MIBG and dopamine transporter scintigraphy
using１２３I-ioflupane can also visualize neurotransmitter functions and contribute to the diagnosis of
dementia. Amyloid positron emission tomography, which can noninvasively detect the earliest event
of Alzheimer’s disease（amyloid β deposition）is also becoming a common imaging examination.
With these imaging examinations, the accuracy of diagnosing dementia is improving. Thus, the
early diagnosis and differentiation of Alzheimer’s disease are gradually becoming possible thanks to
advances in diagnostic imaging. There is currently no fundamental treatment for Alzheimer’s
disease, but treatments are available that improve the symptoms or slow progression, so the early
diagnosis and treatment/intervention remains important.
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